AbbVie Inc. Business Finance Contracts & Agreements

Second Amended and Restated Revolving Credit Agreement, dated as of March 28, 2023, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on March 28, 2023)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 7, 2021)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 7, 2021)

Supplemental Indenture No. 8, dated May 14, 2020, by and between AbbVie Inc. and U.S. Bank National Association, as trustee (Filed With SEC on May 14, 2020)

Supplemental Indenture No. 9, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC,... (Filed With SEC on May 14, 2020)

Registration Rights Agreement, dated May 14, 2020, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., BNP Paribas Securities... (Filed With SEC on May 14, 2020)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 8, 2020)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 8, 2020)

Purchase Agreement, dated November 12, 2019, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Barclays Capital Inc. (acting for themselves and as... (Filed With SEC on November 13, 2019)

Supplemental Indenture No. 6, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services... (Filed With SEC on September 26, 2019)

Underwriting Agreement, dated September 17, 2019, among AbbVie Inc. and Morgan Stanley & Co. International plc, HSBC Bank plc and Merrill Lynch International (acting for... (Filed With SEC on September 23, 2019)

Amended and Restated Revolving Credit Agreement, dated as of August 27, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on August 30, 2019)

364-Day Term Loan Credit Agreement, dated as of July 12, 2019, among AbbVie, certain lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (Filed With SEC on July 16, 2019)

First Amendment to Revolving Credit Agreement, dated as of July 12, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on July 16, 2019)

364-Day Bridge Credit Agreement, dated as of June 25, 2019, among AbbVie, Morgan Stanley Senior Funding, Inc. and the lenders party thereto (Filed With SEC on June 25, 2019)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 3, 2019)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 3, 2019)

Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (Filed With SEC on May 3, 2019)

Underwriting Agreement, dated September 13, 2018, by and among AbbVie Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC, Morgan Stanley & Co.... (Filed With SEC on September 18, 2018)

Supplemental Indenture No. 5, dated September 18, 2018, between AbbVie Inc. and U.S. Bank National Association, as trustee (Filed With SEC on September 18, 2018)

Revolving Credit Agreement, dated as of August 31, 2018, among AbbVie, the lenders and other parties party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (Filed With SEC on September 6, 2018)

First Amendment to 364-Day Term Loan Credit Agreement, dated as of August 31, 2018, among AbbVie, the lenders and other parties party thereto, and Bank of America, N.A., as... (Filed With SEC on September 6, 2018)

364-Day Term Loan Credit Agreement, dated as of May 17, 2018, among AbbVie, the lenders and other parties party thereto, and Bank of America, N.A., as administrative agent (Filed With SEC on May 18, 2018)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (Filed With SEC on May 4, 2018)

ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE INC. PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE INC. 1,400,000,000 0.375% Senior Notes due 2019 1,450,000,000 1.375% Senior Notes due 2024 750,000,000 2.125% Senior Notes due 2028 UNDERWRITING AGREEMENT (Filed With SEC on November 17, 2016)

ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 4 1,400,000,000 0.375% Senior Notes due 2019 1,450,000,000 1.375% Senior Notes due 2024 750,000,000 2.125% Senior Notes due 2028 (Filed With SEC on November 17, 2016)

DATED NOVEMBER 17, 2016 ISSUER PAYING AGENT TRANSFER AGENT REGISTRAR - AND - TRUSTEE AGENCY AGREEMENT relating to Notes issued under a prospectus dated April 27, 2015, as... (Filed With SEC on November 17, 2016)

ABBVIE INC. $1,800,000,000 2.300% Senior Notes due 2021 $1,000,000,000 2.850% Senior Notes due 2023 $2,000,000,000 3.200% Senior Notes due 2026 $1,000,000,000 4.300% Senior Notes... (Filed With SEC on May 12, 2016)

ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 3 $1,800,000,000 2.300% Senior Notes due 2021 $1,000,000,000 2.850% Senior Notes due 2023 $2,000,000,000 3.200% Senior Notes due 2026... (Filed With SEC on May 12, 2016)

ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 6, 2016)